or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    NVO D 0.05 3.78
    SMFG D 0.64 2.09
    MUFG D -0.69 1.91

    Represented by ETF Holdings

    Keywords: Advisory Services Bank Consumer Finance Financial Products Investment Banking Investment Banking Services Project Finance Settlement Services Structured Finance Anti Diabetic Drugs Asset And Liability Management Asset Management Bank Account Bank Deposits Banking Biopharmaceutical Care Insurance Products Cash Management Cash Management Services Commercial Banking
    Industries: Banks - Global Biotechnology

    Recent News for AB Active ETFs, Inc. AB International Low Volatility Equity ETF & its Holdings

    Date Stock Title
    Sep 18 NVO Sanders says generic drugmakers could sell Novo Nordisk Ozempic for less than $100
    Sep 18 NVO Multiple Strong Catalysts And Attractive Valuation Make Novo Nordisk A Buy
    Sep 18 MUFG MUFG Accelerates Medium-Term Plan With Investment in Sakana AI
    Sep 17 NVO Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports
    Sep 17 NVO Weight-loss drug competition heats up with growing pill market
    Sep 17 NVO Novo Nordisk says Ozempic a 'very likely' target in next Medicare drug pricing talks
    Sep 17 NVO US Senator Sanders says generic drugmakers could sell Ozempic for less than $100/month
    Sep 17 NVO 1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)
    Sep 16 NVO Pipeline Moves: Novo Nordisk’s liraglutide scores in Phase III paediatric trial
    Sep 16 NVO This 'forgotten child' is one of the best biotech plays: Analyst
    Sep 15 NVO Do queasy side effects mean the end of weight-loss drug stock hype?
    Sep 15 NVO Should You Invest in This Under-the-Radar Weight Loss Stock?
    Sep 14 NVO 2 Unstoppable Healthcare Stocks to Buy Right Now for Less Than $200
    Sep 13 NVO Pharma Stock Roundup: FDA Approves J&J's Tremfya for Ulcerative Colitis & More
    Sep 13 MUFG MUFG Brings Its Trading to Electronic Age, Except for JGBs
    Sep 12 NVO Why Investors Plowed Into Viking Therapeutics Stock Today
    Sep 12 NVO Novo Nordisk (NVO) Outperforms Broader Market: What You Need to Know
    Sep 12 NVO NVO Oral Obesity Pill Tops Wegovy; LLY, VKTX, GPCR Stocks Rise
    Sep 12 NVO Noom launches cheaper compounded version of Novo's semaglutide
    Sep 12 NVO Each U.S. state has at least 20% of adults living with obesity: CDC
    The adviser seeks to achieve the fund"s investment objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in equity securities of non-U.S. companies, and in companies in at least three countries other than the United States. It invests in companies that are determined by the adviser to offer favorable long-term sustainable profitability, price stability, and attractive valuations.
    Index Fund Venture Capital
    Back to the Main ILOW Page...